Tiamulin Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

Tiamulin Market Report- 2026 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
SEATTLE - Aug. 5, 2021 - PRLog -- Tiamulin Market: Regional Analysis

North America is expected to hold a dominant position in the global Tiamulin Market f over the forecast period, owing to the presence of key players in the region along with several strategic mergers and acquisitions amongst the key players. For instance, in 2015, US-based Eli Lilly and Company acquired Novartis Animal Health Inc. and its product –Denagard (tiamulin hydrogen fumarate) and strengthen the position of Eli Lilly and Company's animal health business arm Elanco US, Inc.

Tiamulin is a pleuromutilin antibiotic drug, which is derived semi-synthetically from natural compound— pleuromutilin—originally produced by the mushroom–clitopilus scyphoides. Tiamulin is primarily used as veterinary medicine for treatment of pneumonia, prophylaxis of dysentery, and mycoplasmal infections in pigs and poultry. It acts by inhibiting protein synthesis at ribosomal level and is present in powder and injectable formulations. Antibiotic properties of Tiamulin aid in treatment of wide range of diseases caused by bacteria.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2036

According to a report by Federal Statistical Office in 2014, the U.S. was the largest producer of poultry meat with around 18% of the total meat produced worldwide. High production of poultry meat is expected to increase demand for Tiamulin antibiotic drug to treat poultry animals from various infections. This in turn is expected to propel growth of the Tiamulin market in the region over the forecast period.

Furthermore, initiatives by various private and government organizations for spreading awareness for use of antibiotics in pig farms is expected to propel global tiamulin market growth over forecast period. For instance, in 2017, National Pork Board celebrated The U.S. Antibiotic Awareness Week and World Antibiotic Awareness Week with organizations such as the U.S. Centers for Disease Control and Prevention (CDC) for spreading awareness for use of antibiotic drugs in pigs.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/tiamulin-market-2036

Tiamulin Market: Restraint

Use of Tiamulin results in some side effects, which is expected to be a major factor hindering growth of the Tiamulin market over the forecast period. Tiamulin injection can cause pain in the animals and long-term treatment with Tiamulin results in its resistance in bacteria.

Tiamulin Market: Key Players

Key players operating in the global Tiamulin market include Elanco Inc., Hester Biosciences Limited, Huvepharma AD, Jiangsu SEL Biochem, Shandong Shengli Co Ltd, and others.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2036

Contact
Mr. Shah
sales@coherentmarketinsights.com
+1-206-701-6702
End
Source: » Follow
Email:***@coherentmarketinsights.com
Posted By:***@coherentmarketinsights.com Email Verified
Tags:Healthcare
Industry:Health
Location:Seattle - Washington - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Coherent Market Insights PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share